RCKT R&D Expenses
Rocket Pharmaceuticals Inc · R&D Expenses
RCKT R&D Expenses
Latest reported$29.50Mperiod ending
RCKT Quarterly R&D Expenses ($1.59M → $29.50M)
Quarterly R&D Expenses
High-resolution chart · PNG
RCKT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 29,497,000 | |
| 31,454,000 | |
| 29,347,000 | |
| 34,068,000 | |
| 42,658,000 | |
| 35,942,000 | |
| 37,357,000 | |
| 42,315,000 | |
| 44,792,000 | |
| 43,760,000 | |
| 41,744,000 | |
| 46,844,000 | |
| 51,383,000 | |
| 46,371,000 | |
| 50,037,000 | |
| 43,383,000 | |
| 41,356,000 | |
| 30,794,000 | |
| 32,161,000 | |
| 39,621,000 | |
| 24,530,000 | |
| 28,309,000 | |
| 51,037,000 | |
| 21,657,000 | |
| 16,731,000 | |
| 16,957,000 | |
| 14,668,000 | |
| 14,829,000 | |
| 13,989,000 | |
| 15,137,000 | |
| 23,680,000 | |
| 13,065,000 | |
| 10,772,000 | |
| 5,743,000 | |
| 654,000 | |
| 2,818,000 | |
| 3,624,000 | |
| 7,097,000 | |
| 9,493,000 | |
| 8,412,000 | |
| 6,465,000 | |
| 7,615,000 | |
| 5,919,000 | |
| 3,612,000 | |
| 1,954,000 | |
| 1,069,000 | |
| 937,000 | |
| 1,243,000 | |
| 1,862,000 | |
| 1,550,000 | |
| 1,592,000 |